Manufacturers Struggle with Breakthrough Drug Development
March 16, 2014 - By: Jill Wechsler BioPharm International
Biopharmace
Determining Criticality–Process Parameters and Quality Attribut
March 15, 2014 - By: Mark Mitchell BioPharm International
FDA and EMA Extend QbD Parallel-Assessment Pilot Program
March 15, 2014 - BioPharm International
FDA and the European Medicines Agency (EMA) have extended the joint pilot program for the parall
…
Design of Experiments for Analytical Method Development and Valid
March 15, 2014 - By: Thomas A. Little, PhD BioPharm International
Design of experiment is a powerful development tool for method characterization and method validation.
Report: Branded Biopharms Most Exposed to Biosimilar Competition
March 8, 2014 - BioPharm International
In a new report on the global biosimilar drug
EMA Collaborates with HTA Assessment Networks
Gaining access to
February 22, 2014 - By: Sean Milmo BioPharm International
High technology assessments are having an impact on biosimilars development in Europe.
The Affordable Care Act's Impact on Innovation in Biopharma
February 22, 2014 - By: Jill E. Sackman, PhD, Rita E. Numerof, PhD, Michael Abrams BioPharm International
The biopharmaceutical industry contempla
Outsourcing Trends in Biopharmaceutical Manufacturing
February 18, 2014 - By: Eric Langer PHARMACEUTICAL TECHNOLOGY
Brazil Emerges as Global Biopharm Collaborator .
The phar
February 6, 2014 - By: Hellen Berger BioPharm International
Brazil is the first Latin American country to emerge as a global biopharmaceutical collaborator
Early Communication with Regulators is Essential for SMEs
January 27, 2014 - by: Sean Milmo, Pharmaceutical Technology
With SMEs gaining wider recognition as the powerhouse of research and innovation in Europe, regulatory agencies are urging companies to engage with regul
…